Načítá se...
Effects of Varying Intranasal Treatment Regimens in ST266-Mediated RGC Neuroprotection
INTRODUCTION: Prior studies showed that intranasally administered ST266, a novel biological secretome of Amnion-derived Multipotent Progenitor cells containing multiple growth factors and anti-inflammatory cytokines, attenuated visual dysfunction and prevented retinal ganglion cell (RGC) loss in exp...
Uloženo v:
| Vydáno v: | J Neuroophthalmol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6522299/ https://ncbi.nlm.nih.gov/pubmed/30829880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WNO.0000000000000760 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|